Does IRBESARTAN Cause Hyperglycaemia? 33 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Hyperglycaemia have been filed in association with IRBESARTAN (Irbesartan). This represents 0.3% of all adverse event reports for IRBESARTAN.
33
Reports of Hyperglycaemia with IRBESARTAN
0.3%
of all IRBESARTAN reports
0
Deaths
20
Hospitalizations
How Dangerous Is Hyperglycaemia From IRBESARTAN?
Of the 33 reports, 20 (60.6%) required hospitalization, and 2 (6.1%) were considered life-threatening.
Is Hyperglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Hyperglycaemia?
INSULIN GLARGINE (1,903)
METFORMIN (1,626)
ALPELISIB (1,575)
DEXAMETHASONE (1,169)
PREDNISONE (1,135)
INSULIN LISPRO (743)
PREDNISOLONE (705)
INSULIN ASPART (646)
INSULIN HUMAN (620)
METHYLPREDNISOLONE (604)
Which IRBESARTAN Alternatives Have Lower Hyperglycaemia Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE